Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection

NCT00671580 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Infections

Interventions

DRUG: PZ-601
DRUG: PZ-601
DRUG: Standard of Care

Sponsor

Protez Pharmaceuticals, Inc.